Asian Phytoceuticals PCL (BKK:APCO)
Thailand · Delayed Price · Currency is THB 2.620
-0.020 (-0.76%)
Jun 12, 2026, 4:36 PM ICT
Asian Phytoceuticals PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 60.46 | 55.41 | 54.71 | 107.49 | 80.92 | 68.7 |
Depreciation & Amortization | 19.4 | 19.55 | 20.5 | 21.98 | 23.13 | 26.81 |
Other Amortization | 0.09 | 0.09 | 0.18 | 0.17 | 0.12 | 0.15 |
Loss (Gain) From Sale of Assets | -8.37 | -0.04 | -2.12 | -0.01 | -0.12 | -0.18 |
Loss (Gain) From Sale of Investments | -2.31 | -6.87 | -1.73 | -0.47 | 0.01 | -2.51 |
Loss (Gain) on Equity Investments | -1.35 | -1.65 | -1.67 | -1.26 | -0.61 | 0.28 |
Provision & Write-off of Bad Debts | - | - | - | - | 0.34 | - |
Other Operating Activities | 0.96 | -0.97 | -15.03 | -13.94 | -10.24 | -8.64 |
Change in Accounts Receivable | -1.31 | 1.27 | -2.67 | 0.42 | 0.13 | 2.87 |
Change in Inventory | -13.58 | -13.05 | -13.95 | 7.45 | 5.42 | 1.07 |
Change in Accounts Payable | 2.89 | 1.55 | 0.21 | 3.12 | 1.62 | -0.13 |
Change in Other Net Operating Assets | -0.88 | -3.08 | -0.76 | -0.86 | -0.52 | -4.03 |
Operating Cash Flow | 56.01 | 52.22 | 37.67 | 124.1 | 100.18 | 84.4 |
Operating Cash Flow Growth | 83.38% | 38.65% | -69.65% | 23.87% | 18.70% | -2.71% |
Capital Expenditures | -1.5 | -0.8 | -2.31 | -3.37 | -0.32 | -1.17 |
Sale of Property, Plant & Equipment | 13.31 | 0.04 | 2.12 | 0.01 | 0.12 | 0.42 |
Sale (Purchase) of Intangibles | - | -0.13 | - | -0.72 | - | - |
Investment in Securities | 52.2 | 51.36 | 7.49 | 16.87 | -40.94 | -6.13 |
Other Investing Activities | 7.84 | 8.99 | 16 | 16.36 | 12.35 | 11.83 |
Investing Cash Flow | 71.85 | 59.46 | 23.3 | 29.14 | -28.78 | 4.95 |
Long-Term Debt Repaid | - | -14.39 | -13.86 | -15.07 | -15.54 | -18.14 |
Net Debt Issued (Repaid) | -14.59 | -14.39 | -13.86 | -15.07 | -15.54 | -18.14 |
Common Dividends Paid | -55.16 | -55.16 | -107.93 | -92.94 | -73.99 | -71.95 |
Other Financing Activities | -1.8 | -1.99 | -2.45 | -1.74 | 1.68 | -0.86 |
Financing Cash Flow | -71.55 | -71.54 | -124.23 | -109.75 | -87.84 | -90.95 |
Net Cash Flow | 56.31 | 40.14 | -63.27 | 43.49 | -16.45 | -1.61 |
Free Cash Flow | 54.51 | 51.42 | 35.36 | 120.72 | 99.86 | 83.22 |
Free Cash Flow Growth | 91.80% | 45.44% | -70.71% | 20.89% | 19.99% | 0.78% |
Free Cash Flow Margin | 27.00% | 25.69% | 16.77% | 41.24% | 39.88% | 37.26% |
Free Cash Flow Per Share | 0.09 | 0.08 | 0.06 | 0.20 | 0.17 | 0.14 |
Cash Interest Paid | 0.95 | 1.13 | 1.59 | 0.66 | 0.57 | 0.86 |
Cash Income Tax Paid | 10.14 | 10.15 | 18.31 | 26.81 | 19.78 | 17.75 |
Levered Free Cash Flow | 49.78 | 41.31 | 29.03 | 99.28 | 87.31 | 74.42 |
Unlevered Free Cash Flow | 50.65 | 42.31 | 30.03 | 99.7 | 87.66 | 74.96 |
Change in Working Capital | -12.87 | -13.3 | -17.17 | 10.14 | 6.65 | -0.22 |